Gw Henssler & Associates LTD Novo Nordisk A S Transaction History

Gw Henssler & Associates LTD

$1.76 Billion
Q3 2024

A detailed history of Gw Henssler & Associates LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Gw Henssler & Associates LTD holds 8,459 shares of NVO stock, worth $750,397. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,459

Previous 8,459 -0.0%

Holding current value

$750,397

Previous $1.21 Million 16.57%

% of portfolio

0.06%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$87.78 - $105.45 $57,495 - $69,069	-655 Reduced 7.19%	8,459 $875,000
Q3 2023 Oct 24, 2023	BUY	$90.94 - $199.54 $414,413 - $909,303	4,557 Added 100.0%	9,114 $828,000
Q4 2022 Feb 03, 2023	SELL	$102.55 - $135.33 $25,945 - $34,238	-253 Reduced 5.26%	4,557 $616,000
Q3 2022 Nov 04, 2022	SELL	$95.28 - $116.93 $26,202 - $32,155	-275 Reduced 5.41%	4,810 $479,000
Q2 2022 Aug 04, 2022	SELL	$103.24 - $121.81 $6,813 - $8,039	-66 Reduced 1.28%	5,085 $567,000
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $152,311 - $184,115	-1,636 Reduced 24.1%	5,151 $572,000
Q4 2021 Jan 28, 2022	BUY	$95.88 - $117.08 $650,737 - $794,621	6,787 New	6,787 $760,000
Q3 2021 Nov 02, 2021	SELL	$84.42 - $106.62 $658,729 - $831,955	-7,803 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$67.66 - $84.76 $94,994 - $119,003	-1,404 Reduced 15.25%	7,803 $654,000
Q1 2021 Apr 28, 2021	SELL	$67.06 - $75.82 $12.9 Million - $14.6 Million	-192,584 Reduced 95.44%	9,207 $621,000
Q4 2020 Feb 02, 2021	BUY	$63.89 - $73.8 $58,459 - $67,527	915 Added 0.46%	201,791 $14.1 Million
Q3 2020 Oct 22, 2020	SELL	$63.69 - $70.22 $12.3 Million - $13.6 Million	-193,094 Reduced 49.01%	200,876 $13.9 Million
Q2 2020 Jul 21, 2020	BUY	$58.54 - $67.94 $1.19 Million - $1.38 Million	20,285 Added 5.43%	393,970 $25.8 Million
Q1 2020 Apr 27, 2020	BUY	$49.46 - $64.78 $3.68 Million - $4.83 Million	74,500 Added 24.9%	373,685 $22.5 Million
Q4 2019 Feb 24, 2020	BUY	$49.86 - $58.26 $842,634 - $984,594	16,900 Added 5.99%	299,185 $17.3 Million
Q3 2019 Nov 18, 2019	BUY	$47.54 - $53.43 $791,445 - $889,502	16,648 Added 6.27%	282,285 $14.6 Million
Q2 2019 Aug 05, 2019	BUY	$46.79 - $52.47 $471,830 - $529,107	10,084 Added 3.95%	265,637 $13.6 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $539,444 - $612,402	11,636 Added 4.77%	255,553 $13.4 Million
Q4 2018 Jan 22, 2019	BUY	$41.54 - $47.25 $922,852 - $1.05 Million	22,216 Added 10.02%	243,917 $11.2 Million
Q3 2018 Oct 23, 2018	BUY	$46.76 - $51.24 $664,927 - $728,632	14,220 Added 6.85%	221,701 $10.5 Million
Q2 2018 Aug 06, 2018	BUY	$44.29 - $50.42 $746,197 - $849,476	16,848 Added 8.84%	207,481 $9.57 Million
Q1 2018 May 04, 2018	BUY	$48.49 - $58.14 $969,266 - $1.16 Million	19,989 Added 11.71%	190,633 $9.39 Million
Q4 2017 Feb 06, 2018	BUY	$47.53 - $53.73 $1.93 Million - $2.19 Million	40,668 Added 31.29%	170,644 $9.16 Million
Q3 2017 Nov 03, 2017	BUY	$41.15 - $49.22 $5.35 Million - $6.4 Million	129,976	129,976 $6.26 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Account

Gw Henssler & Associates LTD Novo Nordisk A S Transaction History